Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kyeonghee Shim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Natural Sciences, Kangwon National University, Chuncheon 24341, Republic of Korea. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation, BK21 Four Program.
Abstract (Originalsprache)
In the last few decades, RNA-based drugs have emerged as a promising candidate in the treatment of various diseases. The introduction of messenger RNA (mRNA) as a vaccine or therapeutic agent enables the production of almost any functional protein/peptide. The key to applying RNA therapy in clinical trials is developing safe and effective delivery systems. Exosomes and lipid nanoparticles (LNPs) have been exploited as promising vehicles for drug delivery. This review discusses the feasibility of exosomes and LNPs as vehicles for mRNA delivery. Cancer/testis antigens (CTAs) show restricted expression in normal tissues and widespread expression in cancer tissues. Many of these CTAs show expression in the sera of patients with cancers. These characteristics of CTAs make them excellent targets for cancer immunotherapy. This review summarizes the roles of CTAs in various life processes and current studies on mRNAs encoding CTAs. Clinical studies present the beneficial effects of mRNAs encoding CTAs in patients with cancers. This review highlight clinical studies employing mRNA-LNPs encoding CTAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, College of Natural Sciences, Kangwon National University, Chuncheon 24341, Republic of Korea.
Förderung
- National Research Foundation of Korea
- National Research Foundation
- BK21 Four Program
Zitieren
APA
Shim, K., Jo, H., & Jeoung, D. (2023). Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914679
Vancouver
Shim K, Jo H, Jeoung D. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914679
BibTeX
@article{Shim2023,
author = {Shim, Kyeonghee and Jo, Hyein and Jeoung, Dooil},
title = {Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914679}
}
EUVIMED